PTX 12.5% 4.5¢ prescient therapeutics limited

Ann: PTX-200 Breast Cancer Trial Progresses, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,664 Posts.
    lightbulb Created with Sketch. 458
    On a completely different bio forum we've recently been discussing whether drugs have to go through the full PhI-II-III process to get to market, and one example that came up was this:

    http://www.cancertherapyadvisor.com...ilzomib-combination-treatment/article/466936/

    I have to read the background and come to grips with the whole story, but am interested in other posters thoughts as we move towards Ph II. (credit to HC user DiamondJoe who provided the link with some background).
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.